BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33417998)

  • 21. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L; Cai K; Wang K; Luo Q
    J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arteriolar C4d in IgA Nephropathy: A Cohort Study.
    Faria B; Canão P; Cai Q; Henriques C; Matos AC; Poppelaars F; Gaya da Costa M; Daha MR; Silva R; Pestana M; Seelen MA
    Am J Kidney Dis; 2020 Nov; 76(5):669-678. PubMed ID: 32439421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microangiopathic Lesions in IgA Nephropathy: A Cohort Study.
    Cai Q; Shi S; Wang S; Ren Y; Hou W; Liu L; Lv J; Haas M; Zhang H
    Am J Kidney Dis; 2019 Nov; 74(5):629-639. PubMed ID: 31103332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy.
    Duan ZY; Cai GY; Bu R; Lu Y; Hou K; Chen XM
    Sci Rep; 2016 Mar; 6():23498. PubMed ID: 27000966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroblastoma suppressor of tumorigenicity 1 is associated with the severity of interstitial fibrosis and kidney function decline in IgA nephropathy.
    Kobayashi H; Satake E; Murata Y; Otsuka H; Tsunemi A; Azuma M; Nakamura Y; Saito T; Abe M
    J Nephrol; 2023 Nov; 36(8):2245-2256. PubMed ID: 37436574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrarenal expression of microRNAs in patients with IgA nephropathy.
    Wang G; Kwan BC; Lai FM; Choi PC; Chow KM; Li PK; Szeto CC
    Lab Invest; 2010 Jan; 90(1):98-103. PubMed ID: 19901913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-21-5p participates in IgA nephropathy by driving T helper cell polarization.
    Xu BY; Meng SJ; Shi SF; Liu LJ; Lv JC; Zhu L; Zhang H
    J Nephrol; 2020 Jun; 33(3):551-560. PubMed ID: 31863364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating MiR-29a, Possible Use as a Biomarker for Monitoring IgA Nephropathy.
    Hu H; Wan Q; Li T; Qi D; Dong X; Xu Y; Chen H; Liu H; Huang H; Wei C; Zhou W; Jiang S; Mo Z; Liao F; Xu Q; He Y
    Iran J Kidney Dis; 2020 Mar; 14(2):107-118. PubMed ID: 32165595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary exosomal miRNA signature of IgA nephropathy: a case-control study.
    Shankar M; Shetty A; N S M; C G S; A K; Tennankore K
    Sci Rep; 2023 Dec; 13(1):21400. PubMed ID: 38049447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy.
    Coppo R; Peruzzi L; Loiacono E; Bergallo M; Krutova A; Russo ML; Cocchi E; Amore A; Lundberg S; Maixnerova D; Tesar V; Perkowska-Ptasińska A; Durlik M; Goumenos D; Gerolymos M; Galesic K; Toric L; Papagianni A; Stangou M; Mizerska-Wasia Membek M; Gesualdo L; Montemurno E; Benozzi L; Cusinato S; Hryszko T; Klinger M; Kamińska D; Krajewska M;
    Nephrol Dial Transplant; 2019 Apr; 34(4):587-596. PubMed ID: 29635535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S; Cai GY; Duan ZY; Liu SW; Wu J; Lv Y; Hou K; Li ZX; Zhang XG; Chen XM
    BMC Nephrol; 2017 Feb; 18(1):63. PubMed ID: 28201996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The MEST score provides earlier risk prediction in lgA nephropathy.
    Barbour SJ; Espino-Hernandez G; Reich HN; Coppo R; Roberts IS; Feehally J; Herzenberg AM; Cattran DC; ;
    Kidney Int; 2016 Jan; 89(1):167-75. PubMed ID: 26759049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
    Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
    Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Zhang Q; Zhao Y; Luo Y; Guo S; Hou H; Han X; Zhou Y
    Ren Fail; 2024 Dec; 46(1):2319326. PubMed ID: 38379319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urine podocyte mRNAs mark disease activity in IgA nephropathy.
    Fukuda A; Sato Y; Iwakiri T; Komatsu H; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S
    Nephrol Dial Transplant; 2015 Jul; 30(7):1140-50. PubMed ID: 25956757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
    Gong WY; Liu M; Luo D; Liu FN; Yin LH; Li YQ; Zhang J; Peng H
    BMC Nephrol; 2019 Apr; 20(1):150. PubMed ID: 31039758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.
    Coppo R; D'Arrigo G; Tripepi G; Russo ML; Roberts ISD; Bellur S; Cattran D; Cook TH; Feehally J; Tesar V; Maixnerova D; Peruzzi L; Amore A; Lundberg S; Di Palma AM; Gesualdo L; Emma F; Rollino C; Praga M; Biancone L; Pani A; Feriozzi S; Polci R; Barratt J; Del Vecchio L; Locatelli F; Pierucci A; Caliskan Y; Perkowska-Ptasinska A; Durlik M; Moggia E; Ballarin JC; Wetzels JFM; Goumenos D; Papasotiriou M; Galesic K; Toric L; Papagianni A; Stangou M; Benozzi L; Cusinato S; Berg U; Topaloglu R; Maggio M; Ots-Rosenberg M; D'Amico M; Geddes C; Balafa O; Quaglia M; Cravero R; Lino Cirami C; Fellstrom B; Floege J; Egido J; Mallamaci F; Zoccali C;
    Nephrol Dial Transplant; 2020 Jun; 35(6):1002-1009. PubMed ID: 30418652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy.
    Li S; Hao H; Li R; Guo S
    Tohoku J Exp Med; 2022 Mar; 256(3):215-223. PubMed ID: 35314529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of microRNA Expression in the Kidneys of Immunoglobulin a Nephropathic Mice.
    Kaneko S; Yanai K; Ishii H; Aomatsu A; Ito K; Hirai K; Ookawara S; Ishibashi K; Morishita Y
    J Vis Exp; 2020 Jul; (161):. PubMed ID: 32716396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.